Overview PGL4001 Versus GnRH-agonist in Uterine Myomas Status: Completed Trial end date: 2010-06-01 Target enrollment: Participant gender: Summary This trial will assess the efficacy and safety of PGL4001 versus GnRH agonist, over a 3-month period for the pre-operative treatment of pre-menopausal women suffering from excessive uterine bleeding due to uterine myoma. Phase: Phase 3 Details Lead Sponsor: PregLem SATreatments: DeslorelinLeuprolideTriptorelin PamoateUlipristal acetate